We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
NCP | Nickel Creek Platinum Corp | 0.02 | 0.005 | 33.33% | 80,986 |
AUMN | Golden Minerals Company | 0.55 | 0.115 | 26.44% | 136,866 |
SMC | Sulliden Mining Capital Inc | 0.025 | 0.005 | 25.00% | 129,000 |
DN | Delta 9 Cannabis Inc | 0.05 | 0.01 | 25.00% | 4,824,438 |
OGD | Orbit Garant Drilling Inc | 0.65 | 0.11 | 20.37% | 13,869 |
ELEF | Silver Elephant Mining Corp | 0.35 | 0.055 | 18.64% | 98,599 |
DII.A | Dorel Industries Inc | 6.80 | 1.05 | 18.26% | 400 |
EXRO | Exro Technologies Inc | 0.93 | 0.14 | 17.72% | 490,622 |
EGLX | Enthusiast Gaming Holdings Inc | 0.20 | 0.03 | 17.65% | 440,249 |
APLI | Appili Therapeutics Inc | 0.035 | 0.005 | 16.67% | 26,576 |
FTU | US Financial 15 Split Corp | 0.42 | 0.06 | 16.67% | 30,089 |
Leading independent proxy advisors ISS and Glass Lewis recommend shareholders vote in favour of the Share Issuance Resolution.ISS expects the combination to provide synergies, enhance scale, and provide human capital benefits through the leadership and expertise of senior executives of each entity.Glass Lewis believes that the board has presented a sufficient case to support its view that the transaction presents an attractive strategic opportunity to combine complementary products and benefit from synergies. Shareholders are encouraged to vote in advance of the proxy voting deadline on April 2, 2024, at 11 a.m. (Mountain Time).CALGARY, AB, March 27, 2024 /CNW/ - Exro Technologies Inc. (TSX: ...
TORONTO, March 25, 2024 /CNW/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") a leading consumer packaged goods company in the cannabis products market, today released its financial results for the fourth quarter and full year ended December 31, 2023. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares ("Shares") and per Share amounts.
Preliminary Financial Highlights Through February 29, 20241Since the end of the fourth quarter 2023, digital asset prices materially changed and our business has benefited from heightened market volatility and increased trading volumes. For the year-to-date period ending February 29, 2024, Galaxy Digital Holdings LP's income before tax is estimated to be approximately $300 million, driven primarily by the appreciation of digital asset prices and growth in our operating businesses. Galaxy Digital Holdings LP's equity capital increased to approximately $2.1 billion over the same period.
MediPharm Labs executive management team thanks those were able to join the call where it discussed 2023 fourth quarter and year-end results. Highlighting that the Company annual revenue and adjusted EBITDA improved by 50%. For those who are unable to participate on the live conference call or webcast on March 27, 2024, a replay is now available here. Management Disclosure and Analysis and Financial Statements are also available on our Investor Page as well the SEDAR+ website www.sedarplus.ca MediPharm Labs looks forward to connecting with investors again for our 2024 first quarter earnings results in May 2024.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 70,870.09 | 1,405.52 | 2.02% | 1.39T | 5,650,000,447 |
ETH | Ethereum | 3,560.46 | 60.40 | 1.73% | 427.21B | 2,893,146,735 |
USDT | Tether USD | 1.00 | 0.00056 | 0.06% | 97.84B | 380,559,482 |
BNB | Binance Coin | 582.84 | 8.72 | 1.52% | 91.98B | 397,431,985 |
SOL | Solana | 188.90 | 2.78 | 1.49% | 82.52B | 1,292,223,372 |
STETH | stETH | 3,548.99 | 84.56 | 2.44% | 34.7B | 5,157,366 |
XRP | Ripple | 0.6254 | 0.0139 | 2.27% | 34.15B | 545,902,559 |
DOGE | Dogecoin | 0.21825 | 0.02821 | 14.84% | 31.34B | 2,873,410,422 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 1,283,382,888 |
ADA | Cardano | 0.6508 | 0.0032 | 0.49% | 22.79B | 140,852,702 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions